Navigation Links
Scientists learn to predict protein-stabilizing ability of small molecules

Prostate cancer is the second leading cause of death among American men. It is estimated that one in six males will develop the disease during his lifetime. However, promising new treatment options have been developed to help combat this threatening disease.

One of the most innovative of these treatments is robotic-assisted laparoscopic prostatectomy (removal of the prostate). The University of Pennsylvania Health System is currently one of only a handful of facilities across the country offering this minimally invasive, high-tech treatment. David I. Lee, M.D., a national expert in robotic surgery, was recruited to Penn and named Chief of the Division of Urology at Penn Presbyterian Medical Center, where the robotic prostate program is based.

There are many factors that make robotics an exceptionally valuable tool in the operating room during prostate surgery, for both the patient and surgeon. “Perhaps two of the most-feared possible long-term effects of a radical prostatectomy are erectile dysfunction and urinary incontinence,?says Dr. Lee. “My specially-trained team and I have discovered that by using the robotic technique there is greater nerve sparing, which provides patients with the best chance for maintaining potency and continence.?br />
Robotic technology offers a number of advantages during surgery. For instance, the robotic “arms?filter even minute tremors of the human hand so to provide steadiness. The robot’s camera also provides a three-dimensional, stereoscopic image of the body’s interior, as opposed to a two-dimensional image on a flat screen. This improved perspective enables depth perception that sharpens the visualization of the prostate and the network of nerves and tissue surrounding it. Additionally, by scaling down the motion of the robotic instruments, the surgeon can perform extremely precise, intricate movements during the procedure. For example, if the surgeon’s hand moves five centimeters, he/she can scale the robotic hand to move only one centimeter.

Robotic technology also offers a number of advantages after surgery. Because laparoscopic surgery is minimally invasive and no large incisions are involved, robotic-assisted surgery provides numerous benefits for prostate cancer patients, including: less pain and scarring, diminished blood loss, a shorter hospital stay and reduced recovery period for a quicker return to daily activities.

The actual robot consists of a tower that manipulates instruments controlled from a console that is situated a few feet from the patient. At the console, the surgeon operates four robotic “arms?and “wrists?using hand and foot controls. One of the robotic arms holds a tiny video camera, one works as a retractor and the other two replicate the surgeon’s exact hand movements. The camera and instruments are inserted through small keyhole incisions in the patient’s abdomen. The surgeon then directs the robotic instruments to dissect the prostate gland and surrounding tissue.

Unlike standard laparoscopic approaches that require counter-intuitive movements by surgeons (whereby the surgeon must move his hand to the left in order to move the mechanical device to the right), the robotic technology affords surgeons the direct, “intuitive?control they exercise in traditional open surgical procedures, seamlessly translating their natural hand, wrist and finger movements at the console into corresponding micro-movements of laparoscopic surgical instruments inside the patient’s body.

Penn has been using fully robotic surgery for cardiac patients for the past three years and is currently studying its use for head and neck cancer surgeries. “The robotic prostate program is a continuation of Penn’s commitment to finding and applying the most precise, most benefi cial surgical techniques to put patients on a quicker road to recovery with better outcomes,?said Dr. Lee.


'"/>

Source:University of Texas Medical Branch at Galveston


Related biology news :

1. Scientists ID molecular switch in liver that triggers harmful effects of saturated and trans fats
2. Scientists Replicate Hepatitis C Virus in Laboratory
3. Scientists detect probable genetic cause of some Parkinsons disease cases
4. Scientists find missing enzyme for tuberculosis iron scavenging pathway
5. Scientists seek answers on what activates deadly anthrax spores
6. Yale Scientists Find MicroRNA Regulates Ras Cancer Gene
7. Scientists collaborate to assess health of global environment
8. Scientists decipher genome of fungus that can cause life-threatening infections
9. Scientists discover the cellular roots of graying hair
10. Scientists rid stem cell culture of key animal cells
11. Scientists develop new color-coded test for protein folding
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/9/2016)... Calif. , Feb. 9, 2016 Vigilant Solutions ... license plate reader (LPR) to develop a lead in a ... commercially available LPR data to locate the suspect vehicle. Due ... of the case have been omitted at the agency,s request. ... for the agency explains, "Our victim was found deceased at ...
(Date:2/5/2016)... DUBLIN , Feb. 5, 2016 /PRNewswire/ ... the addition of the "Global Facial ... offering. --> http://www.researchandmarkets.com/research/5kvw8m/global_facial ) has ... Facial Recognition Market 2016-2020" report to ... Markets ( http://www.researchandmarkets.com/research/5kvw8m/global_facial ) has announced the ...
(Date:2/3/2016)... --> --> Fourth quarter ... up 1,187% compared with fourth quarter of 2014. Gross margin ... (loss: 30.0). Earnings per share increased to SEK 6.39 (loss: ... (neg: 74.7). , --> --> ... 2,900.5 M (233.6), up 1,142% compared with 2014. Gross margin ...
Breaking Biology News(10 mins):
(Date:2/12/2016)... MedGenome,s Commitment Will Help ... of Complex Diseases Such as Cancer, Metabolic Disorders, ... --> --> MedGenome, the market ... leading provider of genomics research services globally, today ... GenomeAsia 100K consortium as a founding member. ...
(Date:2/11/2016)...  Vermillion, Inc. (NASDAQ: VRML ), a bio-analytical ... formation of the Steering Committee for its Pelvic Mass ... Pelvic masses can present physicians and healthcare professionals ... is ruled out, pelvic masses may include cancers of ... ovarian tumors and gastrointestinal and urinary tract masses. ...
(Date:2/11/2016)... , Feb. 11, 2016  Spectra BioPharma Selling Solutions ... that provides biopharma companies the experience, expertise, operational ... deploy outsourced sales teams. Created in concert with ... both the strategic and tactical needs of its ... solutions through both personal and non-personal promotion. ...
(Date:2/11/2016)... SANTA CRUZ, Calif. , Feb. 11, 2016 /PRNewswire/ ... accepting applications to its beta program for a planned ... co-founder, will present the company,s metagenomic genome assembly method ... 2016 Advances in Genome Biology & Technology conference in ... novo  assembly of these highly complex datasets is difficult. ...
Breaking Biology Technology: